| CRS | Cytokine release syndrome |
| ICANS | Neurological toxicity syndrome associated with immunoeffector cell therapy |
| CAR-T | T cells modified with antigen-specific chimeric receptor |
| DLBCL | Diffuse large B-cell lymphoma |
| AXICEL | Axicabtagene ciloleucel |
| BREXU-CEL | Brexucabtagene autoleucel |
| BREYANZI | Lisocabtagene maraleucel |
| MCL | Mantle cell lymphoma |
| B-ALL | B-cell acute lymphocytic leukemia |
| IL | Interleukins |
| TNF | Tumor necrosis factor |
| IFN | Interferon |
| MCP-1 | Monocyte chemotactic protein |
| GM-CSF | Colony-stimulating factor of granulocytes and macrophages |
| BBB | Blood–brain barrier |
| RevMan | Review Manager |
| MeSH | Medical Subject Headings |
| CSF | Cerebrospinal fluid |